Journey Medical (DERM) Interest Expenses (2020 - 2026)

Journey Medical's Interest Expenses history runs 7 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• Quarterly Interest Expenses rose 21.73% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 21.73% YoY) and the FY2025 annual result came in at $26.0 million, down 99.58% from the prior year.
• Interest Expenses was $3.2 million for Q1 2026 at Journey Medical, up from $1.3 million in the prior quarter.
• Across five years, Interest Expenses topped out at $14.7 million in Q2 2025 and bottomed at -$547000.0 in Q4 2023.
• A 5-year average of $4.0 million and a median of $2.6 million in 2025 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses sank 141.79% — and 2024, when it soared 507.87%.
• Journey Medical's Interest Expenses stood at $1.3 million in 2022, then sank by 141.79% to -$547000.0 in 2023, then jumped by 195.8% to $524000.0 in 2024, then surged by 146.76% to $1.3 million in 2025, then jumped by 144.32% to $3.2 million in 2026.
• Business Quant data shows DERM's Interest Expenses at $3.2 million in Q1 2026, $1.3 million in Q4 2025, and $5.5 million in Q3 2025.